feedback welcome

Bupropion-moclobemide

From Psychiatrynet

(Difference between revisions)
Jump to:navigation, search
[checked revision][draft revision]
 
(One intermediate revision not shown)
Line 3: Line 3:
| to = moclobemide  
| to = moclobemide  
| stop =  
| stop =  
-
* Gradually reduce dosage of bupropion to a maximum of 150 mg/ day.
+
{{StopBupropion}}
-
* When a dosage of 150 mg/day is reached, stop administration.
+
| start =  
| start =  
-
* '''Day 1-7:''' wash-out period of one week is necessary.  
+
* '''Day 8-15:''' wash-out period of one week is necessary.  
-
* '''Day 8:''' start moclobemide with 150 mg/day.
+
* '''Day 16:''' start moclobemide with 150 mg/day.
-
* '''Day 12:''' increase moclobemide to 300 mg/day.
+
* '''Day 20:''' increase moclobemide to 300 mg/day.
-
* '''Day 15:''' if necessary, increase moclobemide to 600 mg/day.
+
* '''Day 23:''' if necessary, increase moclobemide to 600 mg/day.
-
| caveat =
+
| info =
{{caveSS}}
{{caveSS}}
-
{{review}}
 
  }}
  }}

Current revision as of 12:42, 7 October 2015

Bupropion
Type Antidepressant
Group other
links
ATC-code N06AX12
Medscape Bupropion
PubChem 444
PubMed Bupropion
Kompas (Dutch) Bupropion
Wikipedia Bupropion
Moclobemide
Type Antidepressant
Group MAO-I
links
Medscape Moclobemide
PubChem 4235
PubMed Moclobemide
Kompas (Dutch) Moclobemide
Wikipedia Moclobemide

Switch medication from bupropion to moclobemide.

Nietinrijdenbord.png Stop bupropion
Eenrichtingbord.png Start moclobemide
Infobord.png More information
The editors of psychiatrienet.nl take the greatest care to provide up-to-date and accurate information on this site. Nevertheless, mistakes and omissions cannot be entirely excluded. No rights devolve from the information provided. The editors and other providers of information to this site accept no responsibility for the content of this site or for the information provided therein; neither do they accept responsibility for possible damages which may derive from the use of the information on this site or from the linked sites. The editorial board accepts no responsibility for the content of the (linked) sites, for access to them, or for the products and services on these sites, nor for the occurrence of errors, viruses, and/or disruptions in service.
Navigation
About